Category Archives: HIV/AIDS

Subsequent HPTN 052 data shows early HIV treatment is even more beneficial to patient, cost-effective

By on .

The good news keeps getting better for the HIV Prevention Trials Network (HPTN) 052 study, which found last year that HIV-infected persons on antiretroviral therapy (ART) were 96 percent less likely to transmit the virus to an uninfected partner through vaginal sex. At the International AIDS Conference (IAC) in Washington this week, two late-breaker sessions […]

HIV/AIDS funding reality check: Tanzanias of the world can’t do it alone

By on .

In Tanzania, an east African country home to 46.2 million people where the national HIV/AIDS prevalence rate is 5.7 percent, the domestic HIV/AIDS response accounts for 10 percent of the national budget, or about $20 million per year. Sixty-five percent of government funding finances antiretroviral therapy (ART). Still, there is a gap of financing of […]

The future of the AIDS response: A fragile affair

By on .

“The 1,200 wealthiest people in the world have about $4.2 trillion in wealth,” said Kent Buse, a senior advisor on policy and strategy at UNAIDS. If that super elite group contributed 0.1 percent of their wealth, he said, it would pay for all of global health. Buse opened what was a sobering discussion about the […]

Congressional leaders say bipartisanship, enthusiasm are key to continued AIDS support on the Hill

By on .

Despite much disruption from protesters – to the visual and audible discontent of event moderator and former Senate Majority Leader Bill Frist (R-TN) – U.S. Congressional leaders were able to get the point across Tuesday that in order to defeat AIDS support must come from both sides of the aisle on Capitol Hill. Rep. Barbara […]

NIDA grants $5 million to pursue combo anti-heroin and HIV vaccine

By on .

It sounds like a fantasy, but researchers are making headway in the development of an effective, safe and easily manufactured combination anti-heroin/HIV vaccine. The National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) has chosen Gary R. Matyas, PhD, to receive the NIDA Avant-Garde Award for Medications Development – a $1 […]

French transaction tax to fund AIDS research to launch August 1

By on .

A new tax on financial transactions is set to launch in France in August, and could generate billions of dollars to help fund the global fight against HIV/AIDS. “We want to create additional innovative financing instruments. This is the aim of the tax on financial transactions which my country has decided to implement from 1 […]

Survey Says: HIV treatment scale up not so impressive in 23 countries

By on .

Much still needs to be done to get treatment to those who need it and to meet the UNAIDS-endorsed goal to achieve universal access by 2015, according to a new survey examining 25 HIV indicators assessing strategies, tools and policies to get the best HIV treatment to more people, sooner. Medecins Sans Frontieres (MSF) released […]

New clinical trials further assess vaginal microbicide ring for HIV prevention

By on .

First potential participants screened Tuesday for inclusion in ASPIRE trial

Scientists presented progress in assessing the potential of a vaginal ring containing the potent antiretroviral drug dapivirine in preventing HIV infection in women, as two studies to assess its safety and efficacy move into Phase III.

U.S. government sets December 1 deadline to release blueprint to end AIDS

By on .

AIDS organizations respond to Secretary of State Hillary Clinton’s speech and proposed blueprint

The U.S. government will be releasing an “AIDS-Free Generation Blueprint” detailing their plans to bring an end to the AID pandemic before the next World AIDS Day – Dec. 1, 2012 – according to a speech by Secretary of State Hillary Clinton Monday at the International AIDS Conference (IAC) in Washington…

The potential of HIV Treatment as Prevention among drug users

By on .

Of the nearly 16 million injection drug users worldwide, approximately 3 million are living with HIV.  And if sub-Saharan Africa is excluded, thirty percent of global HIV cases are attributed to injection drug use and in some cases is the main means of HIV transmission. Dr. Nora Volkow, director of the National Institute on Drug […]